LON:BXP

Beximco Pharmaceuticals (BXP) Share Forecast, Price & News

GBX 39

0.00 (0.00%)

(As of 05/31/2023 ET)

Compare

Today's Range: 38.25
▼
39
50-Day Range: 37.50
▼
44.85
52-Week Range: 37
▼
85

Volume: 7,298 shs
Average Volume: 49,375 shs
Market Capitalization: £173.98 million

P/E Ratio: 557.14
Dividend Yield: 7.69%
Price Target: N/A

Profile Chart Competitors Headlines Options Chain

About Beximco Pharmaceuticals (LON:BXP) Stock

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BXP Stock News Headlines

April 30, 2023 | americanbankingnews.com

Beximco Pharmaceuticals (LON:BXP) Stock Price Crosses Below 200 Day Moving Average of $50.99

March 12, 2023 | msn.com

Beximco to produce medicines in Saudi Arabia from next year

June 1, 2023 | Behind the Markets (Ad)

Is This The End Of Your Retirement?

Soon, the U.S. Government is going to make an announcement that could radically alter your retirement. Two of America's largest banks - Goldman Sachs and J.P. Morgan - have quietly warned their richest clients to prepare for it. The clock is ticking. Find out How to Protect Yourself from the Greatest Crisis Facing Retirees in 70 Years before it's too late.

February 11, 2023 | fool.co.uk

Beximco Pharmaceuticals

October 26, 2022 | wsj.com

Beximco Pharmaceuticals Ltd.

September 8, 2022 | investing.com

Beximco Pharmaceuticals Ltd (BXPH)

January 20, 2022 | nasdaq.com

Beximco Pharma Granted Sub-license To Produce Molupiravir - Quick Facts

November 9, 2021 | nasdaq.com

Beximco Pharma Launches Generic Molnupiravir In Bangladesh To Treat Symptomatic COVID-19

June 1, 2023 | Legacy Research (Affiliate) (Ad)

“Amazon Loophole” could hand you $28,544 in “royalty” payouts

Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.

August 2, 2021 | barrons.com

Beximco Pharmaceuticals Ltd. GDR

May 1, 2021 | lse.co.uk

Beximco Pharma Share Chat

March 26, 2021 | proactiveinvestors.com

Beximco Pharmaceut - Price Monitoring Extension

February 4, 2021 | nasdaq.com

India's Serum delays vaccines for private sale in Bangladesh; focus on state campaigns

January 29, 2021 | msn.com

Colombia police seize boxes of remdesivir in border city

January 22, 2021 | lse.co.uk

Beximco Pharma Share News (BXP)

January 21, 2021 | msn.com

Sanofi selects Beximco as potential buyer

January 21, 2021 | morningstar.com

Beximco Pharmaceuticals to Buy Sanofi's Majority Stake in Bangladesh Unit

January 21, 2021 | lse.co.uk

Beximco Snaps Up 55% Holding In Sanofi's Bangladesh Arm

January 11, 2021 | msn.com

Coronavirus vaccine rollout from February’s first week

January 8, 2021 | marketwatch.com

Respiratory Inhaler Devices Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 2020-2026

January 7, 2021 | msn.com

Govt approves emergency use of Covishield

January 5, 2021 | msn.com

DGHS finalises Covid-19 vaccination guidelines

January 5, 2021 | marketwatch.com

Large Volume Parenterals (LVP) Market Share, Analysis, CAGR and Value Chain Study, Showing Impressive Growth by 2026

January 4, 2021 | msn.com

Bangladesh drug regulator approves import of Oxford-SII's Covid vaccine

December 29, 2020 | msn.com

Private sector may be allowed to import Covid vaccine

December 17, 2020 | marketwatch.com

Respiratory Inhaler Devices Market 2020 Current and Future Trend Scenario Explored In New Latest Research Report

November 24, 2020 | sg.finance.yahoo.com

Beximco Pharmaceuticals Limited (BXP.L)

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Drug Manufacturers - Major
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:BXP
CUSIP: N/A
CIK: N/A
Web: www.beximco-pharma.com
Phone: +880-2-58611001
Fax: N/A
Employees: 5,500
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX 0.07
Trailing P/E Ratio: 557.14
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: 11.79%
Pretax Margin: N/A
Return on Equity: 9.65%
Return on Assets: 6.06%

Debt

Debt-to-Equity Ratio: 24.43
Current Ratio: 1.58
Quick Ratio: 0.37

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 446,110,000
Free Float: N/A
Market Cap: £173.98 million
Optionable: Optionable
Beta: 0.74

Key Executives

Mr. Md. Nazmul Hassan MP
MD & Director

Mr. Mohammad Ali Nawaz
Chief Financial Officer

Mr. S. M. Rabbur Reza
Chief Operating Officer

Mr. Jamal Ahmed Choudhury
Director of Accounts & Fin.

Mr. Rizvi Ul Kabir
Director of Marketing

Mr. M. A. Arshad Bhuiyan
Gen. Mang. of HR

Mr. Zakaria Seraj Chowdhury
Head of Distribution Services & Director of International Marketing

Mr. Mohammad Asad Ullah FCS
Company Sec. & Exec. Director

Mr. Prabir Ghose
Exec. Director of Quality Assurance

Key Competitors

View All Competitors

BXP Stock - Frequently Asked Questions

How have BXP shares performed in 2023?: Beximco Pharmaceuticals' stock was trading at GBX 54 on January 1st, 2023. Since then, BXP stock has decreased by 27.8% and is now trading at GBX 39.
View the best growth stocks for 2023 here.
Is Beximco Pharmaceuticals a good dividend stock?: Beximco Pharmaceuticals (LON:BXP) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 7.24%. BXP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,285.71%. Payout ratios above 75% are not desirable because they may not be sustainable.
What is Beximco Pharmaceuticals' stock symbol?: Beximco Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "BXP."
How do I buy shares of Beximco Pharmaceuticals?: Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Beximco Pharmaceuticals' stock price today?: One share of BXP stock can currently be purchased for approximately GBX 39.
How much money does Beximco Pharmaceuticals make?: Beximco Pharmaceuticals (LON:BXP) has a market capitalization of £173.98 million.
How many employees does Beximco Pharmaceuticals have?: The company employs 5,500 workers across the globe.
How can I contact Beximco Pharmaceuticals?: Beximco Pharmaceuticals' mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The official website for the company is www.beximco-pharma.com. The company can be reached via phone at +880-2-58611001.

This page (LON:BXP) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial